Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1972 Mar 1;135(3):458-75.
doi: 10.1084/jem.135.3.458.

The selective inhibition of macrophage phagocytic receptors by anti-membrane antibodies

The selective inhibition of macrophage phagocytic receptors by anti-membrane antibodies

P Holland et al. J Exp Med. .

Abstract

Rabbit antibodies were prepared against purified mouse macrophages, erythrocytes, and liver lysosomes. In the presence of complement each of these reagents was capable of lysing mouse erythrocytes and macrophages. In the absence of complement, all antisera agglutinated mouse erythrocytes and at high concentration produced a cytotoxic effect on macrophages. At IgG concentrations of 100 microg/ml, no morphological evidence of cytotoxicity was evident. These data suggest the presence of common antigens on the erythrocyte and macrophage plasma membrane. Anti-macrophage, anti-erythrocyte, and anti-lysosomal gamma-globulins and IgG, employed at subtoxic concentrations, all inhibited the attachment and ingestion of opsonized erythrocytes and mycoplasma. This occurred without significant reduction in the phagocytosis of polystyrene particles, formalinized erythrocytes, and yeast cell walls. Each of the anti-membrane IgG antibodies was capable of blocking the Fc receptor on the macrophage plasma membrane. Attachment to the macrophage membrane occurred by means of the Fab region. However, a role for the Fc portion of the molecule was suggested since pepsin-digested IgG was unable to block the receptor. Each of the IgG antibodies produced a partial blockade of the complement receptor and reduced the ingestion of EAC1,4,2,3 by approximately 50%.

PubMed Disclaimer

References

    1. J Exp Med. 1966 Jan 1;123(1):119-44 - PubMed
    1. Exp Cell Res. 1967 Apr;46(1):19-28 - PubMed
    1. J Exp Med. 1967 Jun 1;125(6):1091-104 - PubMed
    1. J Immunol. 1967 Aug;99(2):263-8 - PubMed
    1. Science. 1967 Dec 22;158(3808):1582-5 - PubMed

MeSH terms